Gotowa bibliografia na temat „Sialyltransferases”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Sialyltransferases”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Sialyltransferases"
Rosenstock, Philip, Kaya Bork, Chiara Massa, Philipp Selke, Barbara Seliger i Rüdiger Horstkorte. "Sialylation of Human Natural Killer (NK) Cells Is Regulated by IL-2". Journal of Clinical Medicine 9, nr 6 (11.06.2020): 1816. http://dx.doi.org/10.3390/jcm9061816.
Pełny tekst źródłaJanesch, Bettina, Hirak Saxena, Lyann Sim i Warren W. Wakarchuk. "Comparison of α2,6-sialyltransferases for sialylation of therapeutic proteins". Glycobiology 29, nr 10 (8.07.2019): 735–47. http://dx.doi.org/10.1093/glycob/cwz050.
Pełny tekst źródłaCzuchry, Diana, Paul Desormeaux, Melissa Stuart, Donald L. Jarvis, Khushi L. Matta, Walter A. Szarek i Inka Brockhausen. "Identification and Biochemical Characterization of the Novel α2,3-Sialyltransferase WbwA from Pathogenic Escherichia coli Serotype O104". Journal of Bacteriology 197, nr 24 (21.09.2015): 3760–68. http://dx.doi.org/10.1128/jb.00521-15.
Pełny tekst źródłaYang, Rui, Mengge Gong, Siming Jiao, Juntian Han, Cui Feng, Meishan Pei, Zhongkai Zhou, Yuguang Du i Jianjun Li. "Protein Engineering of Pasteurella multocida α2,3-Sialyltransferase with Reduced α2,3-Sialidase Activity and Application in Synthesis of 3′-Sialyllactose". Catalysts 12, nr 6 (25.05.2022): 579. http://dx.doi.org/10.3390/catal12060579.
Pełny tekst źródłaSticher, U., H. J. Gross i R. Brossmer. "Purification of α 2,6-sialyltransferase from rat liver by dye chromatography". Biochemical Journal 253, nr 2 (15.07.1988): 577–80. http://dx.doi.org/10.1042/bj2530577.
Pełny tekst źródłaLee, Ki-Young, Hyung Gu Kim, Mi Ran Hwang, Jung Il Chae, Jai Myung Yang, Young Choon Lee, Young Kug Choo, Young Ik Lee, Sang-Soo Lee i Su-Il Do. "The Hexapeptide Inhibitor of Galβ1,3GalNAc-specific α2,3-Sialyltransferase as a Generic Inhibitor of Sialyltransferases". Journal of Biological Chemistry 277, nr 51 (11.10.2002): 49341–51. http://dx.doi.org/10.1074/jbc.m209618200.
Pełny tekst źródłaPietrobono, Silvia, i Barbara Stecca. "Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?" Cancers 13, nr 9 (22.04.2021): 2014. http://dx.doi.org/10.3390/cancers13092014.
Pełny tekst źródłaHarduin-Lepers, Anne, Rosella Mollicone, Philippe Delannoy i Rafael Oriol. "The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach". Glycobiology 15, nr 8 (20.04.2005): 805–17. http://dx.doi.org/10.1093/glycob/cwi063.
Pełny tekst źródłaYamamoto, Takeshi, Yoshimitsu Takakura i Hiroshi Tsukamoto. "Bacterial Sialyltransferases". Trends in Glycoscience and Glycotechnology 18, nr 102 (2006): 253–65. http://dx.doi.org/10.4052/tigg.18.253.
Pełny tekst źródłaRatnam, Shobhitha, Arun Nagpurkar i Sailen Mookerjea. "Characterization of serum, liver, and intestinal sialyltransferases from rats treated with colchicine". Biochemistry and Cell Biology 65, nr 3 (1.03.1987): 183–87. http://dx.doi.org/10.1139/o87-023.
Pełny tekst źródłaRozprawy doktorskie na temat "Sialyltransferases"
Chiu, Cecilia P. C. "Crystallographic studies of bacterial sialyltransferases". Thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/31274.
Pełny tekst źródłaMedicine, Faculty of
Biochemistry and Molecular Biology, Department of
Graduate
Sievi, Eeva. "Fate of mammalian golgi sialyltransferases in yeast". Helsinki : University of Helsinki, 2002. http://ethesis.helsinki.fi/julkaisut/eri/biote/vk/sievi/.
Pełny tekst źródłaToivonen, Suvi. "Acceptor specificity studies of fucosyl- and sialyltransferases". Helsinki : University of Helsinki, 2002. http://ethesis.helsinki.fi/julkaisut/eri/biote/vk/toivonen/.
Pełny tekst źródłaBurke, Erin E. "Heavy atom and hydrogen kinetic isotope effect studies on recombinant, mammalian sialyltransferases". [Gainesville, Fla.] : University of Florida, 2005. http://purl.fcla.edu/fcla/etd/UFE0011586.
Pełny tekst źródłaMALTA, Tiago Barros Santos. "Imunodetecção de sialiltransferase e histoquímica de ácidos siálicos no câncer de mama e sua possível aplicação em diagnóstico, prognóstico e terapia". Universidade Federal de Pernambuco, 2016. https://repositorio.ufpe.br/handle/123456789/18431.
Pełny tekst źródłaMade available in DSpace on 2017-03-24T17:41:49Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Dissertação Mestrado - Tiago Barros Santos Malta.pdf: 8207831 bytes, checksum: a5e3ee5357f988c47072c9481326377e (MD5) Previous issue date: 2016-02-25
CAPES, CNPQ, FACEPE
O câncer de mama feminino é o segundo tipo de câncer mais frequente no mundo, com aumento de incidência de 22% a cada ano. Estudos nas últimas décadas revelaram que a transformação maligna está associada a uma variedade de células com padrões de glicosilação alterados, como por exemplo a sialilação. Os ácidos siálicos tem sido relacionados à iniciação e progressão do câncer, tendo assim implicações potenciais na prevenção, diagnóstico e tratamento da doença. Este trabalho avaliou a expressão fenotípica de ST3Gal-I, através da imunohistoquímica, e o perfil de ácido siálico, através da histoquímica com lectinas usando Maackia Amurensis agglutinin II (MAA), em tecidos mamários diagnosticados com fibroadenoma (n=59), carcinoma ductal in situ (CDIS, n=40), carcinoma ductal invasivo (CDI, n=50) e carcinoma lobular (CL, n=42). Todos os tipos de lesões de mama apresentaram alta imunopositividade à ST3Gal-I, sendo observada uma expressão em 93,2% dos casos de Fibroadenoma, 92,5% de CDIS, 96% dos casos CDI e 85,2% de CL. As células apresentaram um padrão de marcação citoplasmático e perinuclear com relação à ST3Gal-I. Diferentes distribuições de resíduos de ácido siálico ⍺2,3-ligados, com um padrão de marcação predominantemente citoplasmático e membranar, foram observados nas lesões de mama estudadas. Os casos de fibroadenoma apresentaram o menor percentual de sialilação entre as lesões analisadas (47,5%), enquanto os de CDI o maior pecentual (98%). Embora este estudo não tenha mostrado diferença significativa na expressão de ST3Gal-I entre as lesões de mama, alterações representativas na presença de ácidos siálicos entre fibroadenoma e lesões malignas (p<0,0001), e também entre CDIS e CDI (p = 0.037) foram notadas. Não foram encontradas correlações significativas entre as expressões de ST3Gal-I e MAA, os marcadores de rotina e as características clinico-histopatológicas dos pacientes. Os resultados indicam uma distribuição particular de ácidos siálicos ⍺2,3-ligados nas células mamárias entre as lesões estudadas sugerindo seu envolvimento na progressão/manutenção do câncer de mama.
The female breast cancer is the second most common type of cancer in the world, with increased incidence of 22% every year. Recent studies in recent decades have revealed that the malignant transformation is associated with a variety of cells with altered glycosylation patterns such as sialylation. Sialic acids have been demonstrated to participate in cancer initiation and progression, thus has potential implications for cancer prevention, diagnosis and treatment. This study evaluated the phenotype expression of ST3Gal-I using immunohistochemistry and the sialic acid residues profile by histochemistry with Maackia amurensis agglutinin II (MAA) in mammary tissues diagnosed as fibroadenoma (n=59), ductal carcinoma in situ (DCIS, n=40), invasive ductal carcinoma (IDC, n=50) and lobular carcinoma (LC, n=42). All types of breast lesions showed high ST3Gal-I immunopositivity, its expression was observed in 93.2% cases of Fibroadenoma, 92.5% of DCIS, 96% of IDC and 85.2% cases of LC. The cells ST3Gal-I staining pattern was mainly cytoplasmatic and perinuclear. The MAA staining in breast lesions showed a diffuse cytoplasmatic and membrane pattern with different distribution of ⍺2,3-linked sialic acids among the lesions studied, fibroadenoma cases showed the lowest percentage among the analyzed lesions (47.5%) while IDC showed the highest (98%). Although this study did not show a significant difference in expression of ST3Gal-I among all lesions, representative alterations in sialic acid content between fibroadenoma and malignant lesions (p<0.0001), and also between CDIS and CDI (p=0.037) were observed. No significant correlations were found between the expressions of ST3Gal-I and MAA, routine markers and clinical-histopathological characteristics of the patients. Results indicate different distribution of ⍺2,3-linked sialic acids on the cells of the studied lesions which seems to be involved in breast cancer progression and/or maintenance.
Pérez, Garay Marta. "Role of alpha 2,3-sialyltransferases ST3Gal III and ST3Gal IV in pancreatic ductal adenocarcinoma". Doctoral thesis, Universitat de Girona, 2011. http://hdl.handle.net/10803/7644.
Pełny tekst źródłaThis work shows that genes that codifying for the enzymes beta-galactoside alpha-2,3-sialyltransferase 3 (ST3Gal III), and in a lower extent beta-galactoside alpha-2,3-sialyltransferase 4 (ST3Gal IV) , are directly implicated in key steps of tumour progression such as adhesion, migration and metastasis formation in the pancreatic adenocarcinoma cell lines Capan-1 and MDAPanc-28. Moreover, Reactive Oxygen Species (ROS) generated in these cell lines during cell proliferation-differentiation processes or by external oxidant stimuli, play a role in the control of ST3Gal III and SLex levels and in the acquisition of a more aggressive phenotype. And, together with the pro-adhesive role of E-Selectin for circulating cells, this work uncovers sE-Selectin dependent migration and VEGF secretion through a SLex depending mechanism, supporting additional pro-metastatic effects for sE-Selectin-SLex interaction.
Preidl, Johannes Jonas [Verfasser]. "Entwicklung von Fluoreszenzpolarisations-Sonden und affinitätsbasierten Photomarkierern für Sialyltransferasen sowie HT-Screening einer Sialyltransferase / Johannes Preidl". Berlin : Freie Universität Berlin, 2011. http://d-nb.info/1026358213/34.
Pełny tekst źródłaAbu-Izneid, Tareq, i n/a. "The Synthesis and Evaluation of Functionalised Carbohydrates as Probes of Tumour Metastasis". Griffith University. Institute for Glycomics, 2005. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20061019.111424.
Pełny tekst źródłaAbu-Izneid, Tareq. "The Synthesis and Evaluation of Functionalised Carbohydrates as Probes of Tumour Metastasis". Thesis, Griffith University, 2005. http://hdl.handle.net/10072/367269.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
Institute for Glycomics
Full Text
Eggers, Katinka Caroline [Verfasser]. "Studies on the structural basis of NCAM functions and on the role of (poly)sialyltransferases and their biosynthetic products in onco- and neurodevelopment / Katinka Caroline Eggers". Hannover : Technische Informationsbibliothek und Universitätsbibliothek Hannover (TIB), 2012. http://d-nb.info/1024938425/34.
Pełny tekst źródłaKsiążki na temat "Sialyltransferases"
Gherardini, Lisa. Sialyltransferase activity as a possible indicator of psychotic disorders. Dublin: University College Dublin, 1998.
Znajdź pełny tekst źródłaBramley, Jennifer. Characterisation of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae. Birmingham: University of Birmingham, 1997.
Znajdź pełny tekst źródłaBruner, Michael John. Characterization of the reaction catalyzed by alpha (2-6) Sialyltransferase. 1999.
Znajdź pełny tekst źródłaCzęści książek na temat "Sialyltransferases"
Basu, Subhash, Manju Basu i Shib Sankar Basu. "Biological Specificity of Sialyltransferases". W Biology of the Sialic Acids, 69–94. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4757-9504-2_3.
Pełny tekst źródłaYamamoto, Takeshi. "Sialyltransferases from marine environments". W Marine Glycobiology, 193–206. Taylor & Francis Group, 6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL 33487-2742: CRC Press, 2016. http://dx.doi.org/10.1201/9781315371399-15.
Pełny tekst źródłaSong, Kwon-Ho, i Cheorl-Ho Kim. "Screening for Xenoantigenic Determinants Formed by Sialyltransferases". W Sialo-Xenoantigenic Glycobiology, 43–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-34094-9_5.
Pełny tekst źródłaHosoguchi, Kensaku, Takahiro Maeda, Jun-ichi Furukawa, Hiroshi Hinou i Shin-Ichiro Nishimura. "An Efficient Strategy for the Exploration of Specific Inhibitors of Sialyltransferases". W Molecular Imaging for Integrated Medical Therapy and Drug Development, 294–301. Tokyo: Springer Japan, 2010. http://dx.doi.org/10.1007/978-4-431-98074-2_29.
Pełny tekst źródłaAlturfan, A. Ata, i Ebru Emekli-Alturfan. "Interaction of Sialyltransferases, Sialidases, and Sialic Acids in Liver Diseases and Applications to Biomarker Discovery". W Biomarkers in Disease: Methods, Discoveries and Applications, 247–64. Dordrecht: Springer Netherlands, 2017. http://dx.doi.org/10.1007/978-94-007-7675-3_19.
Pełny tekst źródłaAlturfan, A. Ata, i Ebru Emekli-Alturfan. "Interaction of Sialyltransferases, Sialidases and Sialic Acids in Liver Diseases and Applications to Biomarker Discovery". W Biomarkers in Disease: Methods, Discoveries and Applications, 1–18. Dordrecht: Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-007-7742-2_19-1.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Monosialoganglioside sialyltransferase". W Enzyme Handbook 12, 1129–32. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-61117-9_244.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Galactosyldiacylglycerol alpha-2,3-sialyltransferase". W Enzyme Handbook 12, 1145–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-61117-9_247.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Lactosylceramide alpha-2,3-sialyltransferase". W Enzyme Handbook 12, 1163–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-61117-9_251.
Pełny tekst źródłaSchomburg, Dietmar, i Dörte Stephan. "Neolactotetraosylceramide alpha-2,3-sialyltransferase". W Enzyme Handbook 12, 1169–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-61117-9_252.
Pełny tekst źródłaStreszczenia konferencji na temat "Sialyltransferases"
Drinnan, Nicholas B., Laurent Bornaghi, Alison Franks, Ylva Strandberg i Judy Halliday. "RESIN BOUND ACCEPTORS FOR SIALYLTRANSFERASES". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.773.
Pełny tekst źródłaLee, Ki-Young, Jung Il Chae, Kyung-Cheol Sohn, Jae-Eun Park, Yunjeong Kang i Su-Il Do. "THE HEXAPEPTIDE INHIBITOR OF ST3Gal I SIALYLTRANSFERASE". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.663.
Pełny tekst źródłaIzume, Masayuki, Syunsuke Kaneko, Katsuhiro Wada, Hideya Yuasa i Hironobu Hashimoto. "SYNTHESIS OF BISUBSTRATE ANALOGUES OF FUCOSYL- AND SIALYLTRANSFERASE". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.600.
Pełny tekst źródłaGalan, M. Carmen, Andre P. Venot, John Glushka, Anne Imberty i GeertJan Boons. "ALPHA-(2,6)-SIALYLTRANSFERASE CATALYZED SIALYLATIONS OF CONFORMATIONALLY CONSTRAINED OLIGOSACCHARIDES". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.455.
Pełny tekst źródłaFan, Tan-chi, Wen-der Lin, Chih-hao Chang, Lan-yi Chang, Zhin-mei Chen, Kay-hooi Khoo i Alice Yu. "Abstract 2305: Role of ST3Gal1 sialyltransferase in breast cancer cells". W Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-2305.
Pełny tekst źródłaSkropeta, Danielle, i Richard R. Schmidt. "RAPID ACCESS TO CHIRAL, NON-RACEMIC SIALYLTRANSFERASE INHIBITORS BASED ON TRANSITION STATE ANALOGUES". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.454.
Pełny tekst źródłaSchultz, Matthew J., Andrew T. Holdbrooks, Asmi Chakraborty, William E. Grizzle, Charles N. Landen, Donald J. Buchsbaum, Michael G. Conner i in. "Abstract 3327: The tumor associated sialyltransferase ST6Gal-I promotes a cancer stem cell phenotype and upregulates stem-related transcription factors". W Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3327.
Pełny tekst źródłaRaporty organizacyjne na temat "Sialyltransferases"
Lau, Joseph T. Sialyltransferase in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2001. http://dx.doi.org/10.21236/ada400483.
Pełny tekst źródłaLau, Joseph T. Sialyltransferase in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2002. http://dx.doi.org/10.21236/ada411655.
Pełny tekst źródłaIvanov, Dimitar, i Katerina Todorova. Multiple Forms of Serum Sialyltransferase in Normal Rats and Rats Bearing Zajdela Hepatoma. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, wrzesień 2020. http://dx.doi.org/10.7546/crabs.2020.09.08.
Pełny tekst źródła